- Animalcare - a leading supplier of veterinary medicines - saw continued growth in the year to the end of June with revenues 11% up on last time.

The group says latest market statistics show sales of veterinary medicines for companion animals in the UK to be flat, so its growth is well ahead of the general market.

It says this trend of growth across the group is reflected in overall underlying earnings in line with expectations.

Animalcare says the performance of its core licensed veterinary medicines group was particularly notable, with revenues up by 22% compared with the prior year.

Revenues for the companion animal identification group were down in the period as a result of continued competition in the market, however unit sales were slightly ahead of management expectations and revenues from related services derived from the microchip database continued to grow against the previous period.

The group said its animal welfare group performed well, with revenues up during the period.

Animalcare says it has traded in line with market expectations for the year.

Story provided by